{"entity":{"edinet_code":"E00714","sec_code":"3951","name_ja":"朝日印刷株式会社","name_en":"ASAHI PRINTING CO.,LTD.","industry":"パルプ・紙","industry_en":"Pulp & Paper"},"names_note":"English company names are as filed: each company's own annual report states its English name on the cover page. For a company that files no annual report, EDINET's filer registry is used instead. The as-filed Japanese name is always returned alongside.","filing":{"doc_id":"S100YEXW","filer_name":"朝日印刷株式会社","filer_name_en":"ASAHI PRINTING CO.,LTD.","period_end":"2026-03-31","filed_date":"2026-06-19","sha256":"6afdb37bce3718ee8d44eb51cb6792772f961d927657370f03e33a5c791c7621","status":"clean"},"basis":{"measurement":"carrying_amount","entity_scope":"parent_only","share_scope":"both","trust_included":"unknown","as_of":"2026-03-31","period_type":"annual","labels":{"measurement":"Balance-sheet carrying amount. Under Japanese GAAP listed equities are carried at market with the valuation difference in other comprehensive income, so carrying amount and acquisition cost diverge enormously on positions bought decades ago.","entity_scope":"The reporting company itself (提出会社) — the holding company, excluding the group holders it names separately.","share_scope":"Listed and unlisted shares together.","trust_included":"The filing does not state whether retirement-benefit-trust shares are included. Never guessed — shares contributed to such a trust leave the holder's balance sheet while the settlor normally keeps the right to instruct the vote.","period_type":"From an annual securities report (有価証券報告書). The policy shareholding table appears only in the annual report."},"not_comparable":"Figures are balance-sheet CARRYING AMOUNT at fiscal year end, from the annual securities report. They are NOT comparable with the acquisition-cost or book-value-reduction figures quoted in press coverage and IR presentations, and NOT comparable with interim (half-year) figures, which this product does not hold. Always state the basis with the number, and use check_claim before setting one of our figures against a published one."},"basis_note":"The basis every yen figure on this response is on. entity_scope is read from the filing's own disclosing entities, not assumed: scale_entities and flows each carry their own entity_scope and share_scope, and a figure quoted for one entity is not the group figure.","holdings":[{"holder_table":"reporting","held_name_raw":"参天製薬株式会社","held_name_en":"SANTEN PHARMACEUTICAL CO., LTD.","held_sec_code":"4536","match_status":"matched","shares":300000,"book_value_yen":535000000,"prior_shares":300000,"prior_book_value_yen":425000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.09325248227072927,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":1.456376752415952,"pct_of_holder_assets":0.7734007950849295,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"テルモ株式会社","held_name_en":"TERUMO CORPORATION","held_sec_code":"4543","match_status":"matched","shares":160000,"book_value_yen":337000000,"prior_shares":160000,"prior_book_value_yen":447000000,"purpose_ja":"医療機器パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.010846846673883616,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.9173812440451885,"pct_of_holder_assets":0.48717022045536684,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"サワイグループホールディングス株式会社","held_name_en":"SAWAI GROUP HOLDINGS Co., Ltd.","held_sec_code":"4887","match_status":"matched","shares":149400,"book_value_yen":330000000,"prior_shares":149400,"prior_book_value_yen":296000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―（注）","pct_outstanding":0.12936673674839755,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.898325847284606,"pct_of_holder_assets":0.47705095771593786,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"キッセイ薬品工業株式会社","held_name_en":"KISSEI PHARMACEUTICAL CO., LTD.","held_sec_code":"4547","match_status":"matched","shares":64500,"book_value_yen":299000000,"prior_shares":64500,"prior_book_value_yen":248000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"有","pct_outstanding":0.1556013406804507,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.8139376616305976,"pct_of_holder_assets":0.4322370798698952,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"三菱ケミカルグループ株式会社","held_name_en":"Mitsubishi Chemical Group Corporation","held_sec_code":"4188","match_status":"matched","shares":332495,"book_value_yen":298000000,"prior_shares":348495,"prior_book_value_yen":256000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.024447527081736267,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.8112154620933715,"pct_of_holder_assets":0.4307914709071196,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"小野薬品工業株式会社","held_name_en":"ONO　PHARMACEUTICAL　CO.,　LTD.","held_sec_code":"4528","match_status":"matched","shares":100000,"book_value_yen":251000000,"prior_shares":100000,"prior_book_value_yen":160000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.02090713115064278,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.6832720838437457,"pct_of_holder_assets":0.3628478496566679,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社ほくほくフィナンシャルグループ","held_name_en":"Hokuhoku Financial Group, Inc.","held_sec_code":"8377","match_status":"matched","shares":40000,"book_value_yen":233000000,"prior_shares":40000,"prior_book_value_yen":102000000,"purpose_ja":"資金借入等の銀行取引の他、各種情報提供等のサービスを受けており、取引先金融機関との円滑かつ緊密な信頼関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―（注）","pct_outstanding":0.033242908743212445,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.6342724921736763,"pct_of_holder_assets":0.33682688832670765,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社ヤマト","held_name_en":"YAMATO CORPORATION","held_sec_code":"1967","match_status":"matched","shares":100000,"book_value_yen":217000000,"prior_shares":100000,"prior_book_value_yen":148000000,"purpose_ja":"発行会社の要請に応え、資本関係を結ぶことで、経営基盤の安定化を図ることを目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"有","pct_outstanding":0.44670073980789726,"pct_unavailable":null,"pct_basis_period_end":"2026-03-20","pct_share_classes":1,"pct_of_holder_equity":0.5907172995780591,"pct_of_holder_assets":0.3136971449222985,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社富山第一銀行","held_name_en":"THE FIRST BANK OF TOYAMA,LTD.","held_sec_code":"7184","match_status":"matched","shares":70000,"book_value_yen":163000000,"prior_shares":70000,"prior_book_value_yen":80000000,"purpose_ja":"資金借入等の銀行取引の他、各種情報提供等のサービスを受けており、取引先金融機関との円滑かつ緊密な信頼関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"有","pct_outstanding":0.11137505230649777,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.4437185245678508,"pct_of_holder_assets":0.2356342609324178,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社ヤクルト本社","held_name_en":"YAKULT HONSHA CO.,LTD.","held_sec_code":"2267","match_status":"matched","shares":61000,"book_value_yen":162000000,"prior_shares":61000,"prior_book_value_yen":174000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"有","pct_outstanding":0.020993398243911186,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.44099632503062475,"pct_of_holder_assets":0.23418865196964223,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"日本新薬株式会社","held_name_en":"Nippon Shinyaku Co., Ltd.","held_sec_code":"4516","match_status":"matched","shares":30000,"book_value_yen":153000000,"prior_shares":30000,"prior_book_value_yen":114000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.04450973594094709,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.41649652919559005,"pct_of_holder_assets":0.22117817130466208,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"わかもと製薬株式会社","held_name_en":"WAKAMOTO PHARMACEUTICAL CO.,LTD.","held_sec_code":"4512","match_status":"matched","shares":410327,"book_value_yen":144000000,"prior_shares":401223,"prior_book_value_yen":127000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。また、持株会を通じた取得に伴い株式数が増加しております。","reciprocal":"有","pct_outstanding":1.1822966827710255,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.39199673336055535,"pct_of_holder_assets":0.20816769063968196,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"中外製薬株式会社","held_name_en":"CHUGAI PHARMACEUTICAL CO., LTD.","held_sec_code":"4519","match_status":"matched","shares":14350,"book_value_yen":123000000,"prior_shares":29350,"prior_book_value_yen":199000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.0008719622393416314,"pct_unavailable":null,"pct_basis_period_end":"2025-12-31","pct_share_classes":1,"pct_of_holder_equity":0.33483054307880766,"pct_of_holder_assets":0.17780990242139502,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社ＳＣＲＥＥＮホールディングス","held_name_en":"SCREEN Holdings Co., Ltd.","held_sec_code":"7735","match_status":"matched","shares":13699,"book_value_yen":122000000,"prior_shares":6616,"prior_book_value_yen":63000000,"purpose_ja":"生産設備等の仕入先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。また、持株会を通じた取得及び株式分割に伴い株式数が増加しております。","reciprocal":"有","pct_outstanding":null,"pct_unavailable":"holding restated onto a share base the issuer has not filed yet","pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.3321083435415816,"pct_of_holder_assets":0.17636429345861945,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":["share split"],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"ゼリア新薬工業株式会社","held_name_en":"ZERIA PHARMACEUTICAL CO., LTD.","held_sec_code":"4559","match_status":"matched","shares":55000,"book_value_yen":120000000,"prior_shares":55000,"prior_book_value_yen":124000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.12477458337199455,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.32666394446712943,"pct_of_holder_assets":0.17347307553306832,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"コーセル株式会社","held_name_en":"COSEL CO.,LTD.","held_sec_code":"6905","match_status":"matched","shares":66400,"book_value_yen":74000000,"prior_shares":66400,"prior_book_value_yen":70000000,"purpose_ja":"地元公開企業を応援することを目的として保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"有","pct_outstanding":0.16142285494795086,"pct_unavailable":null,"pct_basis_period_end":"2026-05-20","pct_share_classes":1,"pct_of_holder_equity":0.20144276575472983,"pct_of_holder_assets":0.10697506324539212,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社小森コーポレーション","held_name_en":"KOMORI CORPORATION","held_sec_code":"6349","match_status":"matched","shares":42300,"book_value_yen":64000000,"prior_shares":42300,"prior_book_value_yen":51000000,"purpose_ja":"生産設備等の仕入先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"有","pct_outstanding":0.07910602339069736,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.17422077038246903,"pct_of_holder_assets":0.09251897361763643,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社富山銀行","held_name_en":"The Bank of Toyama,Ltd.","held_sec_code":"8365","match_status":"matched","shares":21300,"book_value_yen":47000000,"prior_shares":21300,"prior_book_value_yen":32000000,"purpose_ja":"資金借入等の銀行取引の他、各種情報提供等のサービスを受けており、取引先金融機関との円滑かつ緊密な信頼関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"有","pct_outstanding":0.39924275083878463,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.1279433782496257,"pct_of_holder_assets":0.06794362125045175,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社資生堂","held_name_en":"Shiseido Company, Limited","held_sec_code":"4911","match_status":"matched","shares":7800,"book_value_yen":24000000,"prior_shares":3000,"prior_book_value_yen":8000000,"purpose_ja":"化粧品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。また、債券の償還により株式に転換し、株式数が増加しております。","reciprocal":"―","pct_outstanding":null,"pct_unavailable":"holding restated onto a share base the issuer has not filed yet","pct_basis_period_end":"2025-12-31","pct_share_classes":1,"pct_of_holder_equity":0.06533278889342589,"pct_of_holder_assets":0.03469461510661366,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"富士製薬工業株式会社","held_name_en":"Fuji Pharma Co.,Ltd.","held_sec_code":"4554","match_status":"matched","shares":10000,"book_value_yen":23000000,"prior_shares":10000,"prior_book_value_yen":13000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.04082382478414403,"pct_unavailable":null,"pct_basis_period_end":"2025-09-30","pct_share_classes":1,"pct_of_holder_equity":0.06261058935619981,"pct_of_holder_assets":0.03324900614383809,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"ダイト株式会社","held_name_en":"Daito Pharmaceutical Co.,Ltd.","held_sec_code":"4577","match_status":"matched","shares":14014,"book_value_yen":20000000,"prior_shares":7007,"prior_book_value_yen":15000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。また、株式分割に伴い株式数が増加しております。","reciprocal":"有","pct_outstanding":0.04859529970337934,"pct_unavailable":null,"pct_basis_period_end":"2026-05-31","pct_share_classes":1,"pct_of_holder_equity":0.054443990744521574,"pct_of_holder_assets":0.028912179255511383,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":["share split"],"note_refs":[],"share_ratio":2.0,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"持田製薬株式会社","held_name_en":"Mochida Pharmaceutical Co.,Ltd.","held_sec_code":"4534","match_status":"matched","shares":5600,"book_value_yen":19000000,"prior_shares":5600,"prior_book_value_yen":17000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.015797030722403856,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.051721791207295496,"pct_of_holder_assets":0.027466570292735814,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"扶桑薬品工業株式会社","held_name_en":"Fuso Pharmaceutical Industries, Ltd.","held_sec_code":"4538","match_status":"matched","shares":6500,"book_value_yen":15000000,"prior_shares":6500,"prior_book_value_yen":15000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.07613854356805597,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.04083299305839118,"pct_of_holder_assets":0.02168413444163354,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社ツムラ","held_name_en":"TSUMURA & CO.","held_sec_code":"4540","match_status":"matched","shares":3500,"book_value_yen":13000000,"prior_shares":3320,"prior_book_value_yen":14000000,"purpose_ja":"医薬品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。また、持株会を通じた取得に伴い株式数が増加しております。","reciprocal":"―","pct_outstanding":0.004648823737350916,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.03538859398393902,"pct_of_holder_assets":0.0187929165160824,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"竹田iPホールディングス株式会社","held_name_en":"TAKEDA iP HOLDINGS CO., LTD．","held_sec_code":"7875","match_status":"matched","shares":20000,"book_value_yen":12000000,"prior_shares":10000,"prior_book_value_yen":9000000,"purpose_ja":"商品等の仕入先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。また、株式分割に伴い株式数が増加しております。","reciprocal":"―（注）","pct_outstanding":null,"pct_unavailable":"holding restated onto a share base the issuer has not filed yet","pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.032666394446712946,"pct_of_holder_assets":0.01734730755330683,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":["share split"],"note_refs":[],"share_ratio":2.0,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社ミルボン","held_name_en":"Ｍｉｌｂｏｎ　Ｃｏ．，Ｌｔｄ．","held_sec_code":"4919","match_status":"matched","shares":4000,"book_value_yen":10000000,"prior_shares":4000,"prior_book_value_yen":11000000,"purpose_ja":"化粧品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.012586281318365141,"pct_unavailable":null,"pct_basis_period_end":"2025-12-31","pct_share_classes":1,"pct_of_holder_equity":0.027221995372260787,"pct_of_holder_assets":0.014456089627755691,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社コーセーホールディングス","held_name_en":"KOSÉ Holdings Corporation","held_sec_code":"4922","match_status":"matched","shares":1600,"book_value_yen":9000000,"prior_shares":1600,"prior_book_value_yen":9000000,"purpose_ja":"化粧品パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.0028033613213335217,"pct_unavailable":null,"pct_basis_period_end":"2025-12-31","pct_share_classes":1,"pct_of_holder_equity":0.02449979583503471,"pct_of_holder_assets":0.013010480664980123,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"不二ラテックス株式会社","held_name_en":"FUJI LATEX CO., LTD.","held_sec_code":"5199","match_status":"matched","shares":4388,"book_value_yen":8000000,"prior_shares":4168,"prior_book_value_yen":7000000,"purpose_ja":"医療機器パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。また、持株会を通じた取得に伴い株式数が増加しております。","reciprocal":"―","pct_outstanding":0.3461935670166209,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.021777596297808628,"pct_of_holder_assets":0.011564871702204554,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社ＭＴＧ","held_name_en":"ＭＴＧ Ｃｏ., Ｌｔｄ.","held_sec_code":"7806","match_status":"matched","shares":1200,"book_value_yen":7000000,"prior_shares":1200,"prior_book_value_yen":3000000,"purpose_ja":"取引先との安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.003054972084174257,"pct_unavailable":null,"pct_basis_period_end":"2025-09-30","pct_share_classes":1,"pct_of_holder_equity":0.01905539676058255,"pct_of_holder_assets":0.010119262739428984,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"セーラー万年筆株式会社","held_name_en":"The Sailor Pen Co.,Ltd.","held_sec_code":"7992","match_status":"matched","shares":29106,"book_value_yen":3000000,"prior_shares":26091,"prior_book_value_yen":3000000,"purpose_ja":"筆記用具パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。また、持株会を通じた取得に伴い株式数が増加しております。","reciprocal":"―","pct_outstanding":0.09818726990204954,"pct_unavailable":null,"pct_basis_period_end":"2025-12-31","pct_share_classes":1,"pct_of_holder_equity":0.008166598611678236,"pct_of_holder_assets":0.0043368268883267076,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社みずほフィナンシャルグループ","held_name_en":"Mizuho Financial Group, Inc.","held_sec_code":"8411","match_status":"matched","shares":540,"book_value_yen":3000000,"prior_shares":540,"prior_book_value_yen":2000000,"purpose_ja":"資金借入等の銀行取引の他、各種情報提供等のサービスを受けており、取引先金融機関との円滑かつ緊密な信頼関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":2.211488590344318e-05,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.008166598611678236,"pct_of_holder_assets":0.0043368268883267076,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社メニコン","held_name_en":"Menicon Co., Ltd.","held_sec_code":"7780","match_status":"matched","shares":1898,"book_value_yen":3000000,"prior_shares":1596,"prior_book_value_yen":1000000,"purpose_ja":"医療機器パッケージ等の取引先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。また、持株会を通じた取得に伴い株式数が増加しております。","reciprocal":"―","pct_outstanding":0.002540527708028528,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.008166598611678236,"pct_of_holder_assets":0.0043368268883267076,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"日本紙パルプ商事株式会社","held_name_en":"Japan Pulp & Paper Co., Ltd.","held_sec_code":"8032","match_status":"matched","shares":2000,"book_value_yen":2000000,"prior_shares":2000,"prior_book_value_yen":1000000,"purpose_ja":"原材料等の仕入先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"有","pct_outstanding":0.0017526423932121562,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.005444399074452157,"pct_of_holder_assets":0.0028912179255511385,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"第一生命ホールディングス株式会社","held_name_en":"Daiichi Life Group, Inc.","held_sec_code":"8750","match_status":"matched","shares":1600,"book_value_yen":2000000,"prior_shares":1600,"prior_book_value_yen":1000000,"purpose_ja":"保険取引の他、各種情報提供等のサービスを受けており、取引先金融機関との円滑かつ緊密な信頼関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―（注）","pct_outstanding":4.421072910400495e-05,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.005444399074452157,"pct_of_holder_assets":0.0028912179255511385,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"北越コーポレーション株式会社","held_name_en":"Hokuetsu Corporation","held_sec_code":"3865","match_status":"matched","shares":3000,"book_value_yen":2000000,"prior_shares":3000,"prior_book_value_yen":3000000,"purpose_ja":"原材料等の仕入先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。また、医薬品市場向け高品質コートボールを共同開発する等、協力関係にあります。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"有","pct_outstanding":0.0018806240768251485,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.005444399074452157,"pct_of_holder_assets":0.0028912179255511385,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"株式会社中京医薬品","held_name_en":"CHUKYOIYAKUHIN CO.,LTD.","held_sec_code":"4558","match_status":"matched","shares":5590,"book_value_yen":1000000,"prior_shares":5590,"prior_book_value_yen":1000000,"purpose_ja":"取引先との安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"―","pct_outstanding":0.052362720216150314,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0027221995372260785,"pct_of_holder_assets":0.0014456089627755693,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"丸三証券株式会社","held_name_en":"Marusan Securities Co., Ltd.","held_sec_code":"8613","match_status":"matched","shares":1000,"book_value_yen":0,"prior_shares":1000,"prior_book_value_yen":0,"purpose_ja":"証券取引の他、従業員持株会等の取引を行っており、取引先金融機関との円滑かつ緊密な信頼関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"有","pct_outstanding":0.0015080553833942774,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0,"pct_of_holder_assets":0.0,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"平和紙業株式会社","held_name_en":"HEIWA PAPER CO.,LTD.","held_sec_code":"9929","match_status":"matched","shares":1000,"book_value_yen":0,"prior_shares":1000,"prior_book_value_yen":0,"purpose_ja":"原材料等の仕入先であり、安定的・長期的な取引関係の維持・強化を目的に保有しております。定量的な保有効果については秘密保持の観点から記載しておりませんが、保有意義や取引状況、経済合理性を取締役会において検証し、保有の合理性があると判断しております。","reciprocal":"有","pct_outstanding":0.010809505489985697,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0,"pct_of_holder_assets":0.0,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"協和キリン株式会社","held_name_en":"Kyowa Kirin Co., Ltd.","held_sec_code":"4151","match_status":"matched","shares":null,"book_value_yen":null,"prior_shares":47000,"prior_book_value_yen":102000000,"purpose_ja":"―","reciprocal":"―","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2025-12-31","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"鳥居薬品株式会社","held_name_en":"TORII PHARMACEUTICAL CO., LTD.","held_sec_code":null,"match_status":"matched","shares":null,"book_value_yen":null,"prior_shares":1000,"prior_book_value_yen":4000000,"purpose_ja":"―","reciprocal":"―","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2024-12-31","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":null,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false},{"holder_table":"reporting","held_name_raw":"久光製薬株式会社","held_name_en":"HISAMITSU PHARMACEUTICAL CO.,INC.","held_sec_code":null,"match_status":"matched","shares":null,"book_value_yen":null,"prior_shares":75551,"prior_book_value_yen":305000000,"purpose_ja":"―","reciprocal":"有","pct_outstanding":null,"pct_unavailable":null,"pct_basis_period_end":"2025-02-28","pct_share_classes":1,"pct_of_holder_equity":null,"pct_of_holder_assets":null,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36735000000,"holder_total_assets_yen":69175000000,"implausible":false,"reciprocal_held_both_ways":true,"corporate_actions":[],"note_refs":[],"share_ratio":null,"reclassified_to_pure":false}],"holders":[{"holder_name":"株式会社小森コーポレーション","holder_name_en":"KOMORI CORPORATION","holder_sec_code":"6349","doc_id":"S100YJ3O","period_end":"2026-03-31","holder_table":"reporting","shares":1363465,"book_value_yen":1191000000,"prior_shares":1353372,"prior_book_value_yen":1216000000,"purpose_ja":"取引関係の維持・発展目的で保有しており、販売取引をしております。取引関係を強化するため、取引先持株会に参加し保有株式数を増やしております。","reciprocal":"有","pct_outstanding":6.5918415032124384,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.9691120947793256,"pct_of_holder_assets":0.6685077290943994,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":122896000000,"holder_total_assets_yen":178158000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"久光製薬株式会社","holder_name_en":"HISAMITSU PHARMACEUTICAL CO.,INC.","holder_sec_code":"4530","doc_id":"S100VT69","period_end":"2025-02-28","holder_table":"reporting","shares":336932,"book_value_yen":300000000,"prior_shares":335044,"prior_book_value_yen":304000000,"purpose_ja":"医薬品事業の取引先であり、取引関係維持・強化を図るため。取引先持株会を通じた取得による増加。","reciprocal":"有","pct_outstanding":1.5852916224330442,"pct_unavailable":null,"pct_basis_period_end":"2025-03-31","pct_share_classes":1,"pct_of_holder_equity":0.10737025199798143,"pct_of_holder_assets":0.08744622057434678,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":279407000000,"holder_total_assets_yen":343068000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社ほくほくフィナンシャルグループ","holder_name_en":"Hokuhoku Financial Group, Inc.","holder_sec_code":"8377","doc_id":"S100YBV5","period_end":"2026-03-31","holder_table":"largest","shares":300000,"book_value_yen":262000000,"prior_shares":300000,"prior_book_value_yen":269000000,"purpose_ja":"株式保有を通して企業の成長を支援し、長期的な取引関係を維持するために保有しております。株式数は増加しておりません。","reciprocal":"有","pct_outstanding":1.4503873960561742,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0357666973823419,"pct_of_holder_assets":0.0015444666387837383,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":732525000000,"holder_total_assets_yen":16963785000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社　富山第一銀行","holder_name_en":"THE FIRST BANK OF TOYAMA,LTD.","holder_sec_code":"7184","doc_id":"S100YCB2","period_end":"2026-03-31","holder_table":"reporting","shares":300000,"book_value_yen":262000000,"prior_shares":300000,"prior_book_value_yen":269000000,"purpose_ja":"富山県内に本社・営業拠点を置き、印刷包材・包装時システム事業を起点に雇用創出や地元企業との取引を通じ、地元地域の発展や地元経済へ貢献しており、また医薬品包装資材においてトップクラスのシェアを誇るなど、投資効果を有することから保有の妥当性を確認しております。医薬品包材事業として当地の主要産業である医薬品業界に多くの取引先を有することから、同社との銀行取引拡大を図るためにも株式の相互保有により関係強化を図っております。","reciprocal":"有","pct_outstanding":1.4503873960561742,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.131943395276225,"pct_of_holder_assets":0.015397635111309621,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":198570000000,"holder_total_assets_yen":1701560000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社　富山銀行","holder_name_en":"The Bank of Toyama,Ltd.","holder_sec_code":"8365","doc_id":"S100YFUZ","period_end":"2026-03-31","holder_table":"reporting","shares":178000,"book_value_yen":155000000,"prior_shares":178000,"prior_book_value_yen":160000000,"purpose_ja":"当行の営業基盤である富山県に本社及び工場を置く企業として、地域経済の発展に重要な役割を担っており、取引関係を維持・強化することにより、当社及び当行の中長期的な企業価値の向上を図るため保有しております。","reciprocal":"有","pct_outstanding":0.8605631883266635,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.48485985985985985,"pct_of_holder_assets":0.02764584072785256,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":31968000000,"holder_total_assets_yen":560663000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"丸三証券株式会社","holder_name_en":"Marusan Securities Co., Ltd.","holder_sec_code":"8613","doc_id":"S100YC95","period_end":"2026-03-31","holder_table":"reporting","shares":173000,"book_value_yen":151000000,"prior_shares":173000,"prior_book_value_yen":155000000,"purpose_ja":"株式等の引受をはじめとする証券関連ビジネスの取引先として、取引関係の維持・強化を目的として株式を保有しております。","reciprocal":"有","pct_outstanding":0.8363900650590606,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.29352305419485264,"pct_of_holder_assets":0.17066775170667753,"holder_equity_basis":"parent_only","holder_equity_yen":51444000000,"holder_total_assets_yen":88476000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"サワイグループホールディングス株式会社","holder_name_en":"SAWAI GROUP HOLDINGS Co., Ltd.","holder_sec_code":"4887","doc_id":"S100YITS","period_end":"2026-03-31","holder_table":"largest","shares":165200,"book_value_yen":144000000,"prior_shares":165200,"prior_book_value_yen":149000000,"purpose_ja":"添付文書等の発注先として良好な関係を維持していくことの重要性を考慮して保有しております。なお、定期的に定量的な保有効果を検証しております。","reciprocal":"有","pct_outstanding":0.7986799927616,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.08064696789802639,"pct_of_holder_assets":0.04000900202545573,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":178556000000,"holder_total_assets_yen":359919000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社Ｔ＆Ｋ　ＴＯＫＡ","holder_name_en":"T&K TOKA CO., LTD.","holder_sec_code":"4636","doc_id":"S100R1WE","period_end":"2023-03-31","holder_table":"reporting","shares":135182,"book_value_yen":118000000,"prior_shares":130566,"prior_book_value_yen":107000000,"purpose_ja":"取引先との関係強化による収益拡大のため保有しており、主に販売取引を行っております。保有目的強化のために取引先持株会を通じた株式の取得により株式数が増加しております。 ","reciprocal":"無","pct_outstanding":0.6175421118613612,"pct_unavailable":null,"pct_basis_period_end":"2023-03-31","pct_share_classes":1,"pct_of_holder_equity":0.24020845208044947,"pct_of_holder_assets":0.17392586041712726,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":49124000000,"holder_total_assets_yen":67845000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"株式会社ヤクルト本社","holder_name_en":"YAKULT HONSHA CO.,LTD.","holder_sec_code":"2267","doc_id":"S100YCBJ","period_end":"2026-03-31","holder_table":"reporting","shares":112800,"book_value_yen":98000000,"prior_shares":112800,"prior_book_value_yen":101000000,"purpose_ja":"医薬品、化粧品の包装資材等の調達における協力関係の形成において、同社との良好な関係の維持、強化を図るため、継続して保有しています。","reciprocal":"有","pct_outstanding":0.5453456609171216,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.014977358207974373,"pct_of_holder_assets":0.010738808079966864,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":654321000000,"holder_total_assets_yen":912578000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"キッセイ薬品工業株式会社","holder_name_en":"KISSEI PHARMACEUTICAL CO., LTD.","holder_sec_code":"4547","doc_id":"S100YFN3","period_end":"2026-03-31","holder_table":"reporting","shares":110200,"book_value_yen":96000000,"prior_shares":110200,"prior_book_value_yen":99000000,"purpose_ja":"同社は医薬品事業における取引先の一つであるため、取引関係維持・強化のために株式を保有しています。2026年４月の取締役会において、個別の政策保有株式について、保有目的、保有に伴う便益・リスク、資本コスト等を総合的に検証し、経済合理性・戦略妥当性を確認しています。","reciprocal":"有","pct_outstanding":0.532775636817968,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.041462234814456496,"pct_of_holder_assets":0.03489817729728158,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":231536000000,"holder_total_assets_yen":275086000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"ａｒｔｉｅｎｃｅ株式会社","holder_name_en":"artience Co., Ltd.","holder_sec_code":"4634","doc_id":"S100XRLA","period_end":"2025-12-31","holder_table":"reporting","shares":110839,"book_value_yen":96000000,"prior_shares":108352,"prior_book_value_yen":96000000,"purpose_ja":"印刷・情報関連事業の取引を行っており、取引関係の維持と強化を目的として保有しております。取引先企業の持株会の継続加入により、株式数が増加しております。","reciprocal":"無","pct_outstanding":0.5358649619715676,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.03462953610850588,"pct_of_holder_assets":0.020752269779507133,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":277220000000,"holder_total_assets_yen":462600000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"株式会社ヤマト","holder_name_en":"YAMATO CORPORATION","holder_sec_code":"1967","doc_id":"S100YBIH","period_end":"2026-03-20","holder_table":"reporting","shares":102200,"book_value_yen":90344000,"prior_shares":102200,"prior_book_value_yen":92797000,"purpose_ja":"取引先であり、良好な関係維持を目的とし保有しています。","reciprocal":"有","pct_outstanding":0.4940986395898034,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.21081226776004802,"pct_of_holder_assets":0.14626718356890955,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":42855191000,"holder_total_assets_yen":61766418000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"日本紙パルプ商事株式会社","holder_name_en":"Japan Pulp & Paper Co., Ltd.","holder_sec_code":"8032","doc_id":"S100YF3W","period_end":"2026-03-31","holder_table":"reporting","shares":63670,"book_value_yen":56000000,"prior_shares":61151,"prior_book_value_yen":55000000,"purpose_ja":"同社は当社グループの国内卸売事業における顧客の１社であり、取引により得られる収益と中長期的な取引関係の維持・強化を目的として保有しております。取引先持株会加入のため、株式数が増加しております。","reciprocal":"有","pct_outstanding":0.3078205516896554,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.03974252521166443,"pct_of_holder_assets":0.014187847095545016,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":140907000000,"holder_total_assets_yen":394704000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"リンテック株式会社","holder_name_en":"LINTEC Corporation","holder_sec_code":"7966","doc_id":"S100YBFC","period_end":"2026-03-31","holder_table":"reporting","shares":62774,"book_value_yen":54000000,"prior_shares":57468,"prior_book_value_yen":51000000,"purpose_ja":"印刷情報材事業における顧客であり、良好な取引関係の維持を目的として同社持株会を通じて保有株式数が増加した理由は、同社持株会を通じた株式取得","reciprocal":"無","pct_outstanding":0.30348872800010096,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.020910780669144983,"pct_of_holder_assets":0.015756072653001676,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":258240000000,"holder_total_assets_yen":342725000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"コーセル株式会社","holder_name_en":"COSEL CO.,LTD.","holder_sec_code":"6905","doc_id":"S100YUI9","period_end":"2026-05-20","holder_table":"reporting","shares":55440,"book_value_yen":47000000,"prior_shares":55440,"prior_book_value_yen":48000000,"purpose_ja":"地元株式上場企業を応援し、地域経済の発展に貢献するため","reciprocal":"有","pct_outstanding":0.268031590791181,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.09010217970592183,"pct_of_holder_assets":0.07758848388800846,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52163000000,"holder_total_assets_yen":60576000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社大和証券グループ本社","holder_name_en":"Daiwa Securities Group Inc.","holder_sec_code":"8601","doc_id":"S100YCMP","period_end":"2026-03-31","holder_table":"reporting","shares":49896,"book_value_yen":43000000,"prior_shares":49896,"prior_book_value_yen":44000000,"purpose_ja":"当社の定量基準を充足しており、また、当社の有価証券関連業における取引先であり、証券関連ビジネスの拡大を目的とした良好な関係の維持・強化を図るため、継続保有しています。","reciprocal":"無","pct_outstanding":0.2412284317120629,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0021018579935859114,"pct_of_holder_assets":0.00011292714891041321,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":2045809000000,"holder_total_assets_yen":38077646000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"日本製紙株式会社","holder_name_en":"Nippon Paper Industries Co., Ltd.","holder_sec_code":"3863","doc_id":"S100YJ5X","period_end":"2026-03-31","holder_table":"reporting","shares":48510,"book_value_yen":42000000,"prior_shares":48510,"prior_book_value_yen":43000000,"purpose_ja":"・当社は保有株式について、保有するうえでの中長期的な経済合理性や取引先との総合的な関係の維持・強化の観点から判断し保有しています。定量的な保有効果については、守秘義務等により記載しません。保有の合理性については、「a．保有方針及び保有の合理性を検証する方法並びに個別銘柄の保有の適否に関する取締役会等における検証の内容」に基づき、銘柄ごとに取締役会において検証しています。","reciprocal":"無","pct_outstanding":0.23452764194228337,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.00777048215841793,"pct_of_holder_assets":0.0024159049375919984,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":540507000000,"holder_total_assets_yen":1738479000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"北陸電気工事株式会社","holder_name_en":"HOKURIKU ELECTRICAL CONSTRUCTION CO.,LTD.","holder_sec_code":"1930","doc_id":"S100YI00","period_end":"2026-03-31","holder_table":"reporting","shares":46981,"book_value_yen":41000000,"prior_shares":46044,"prior_book_value_yen":41000000,"purpose_ja":"①・②当社の営業基盤である北陸の主要企業であり、設備工事業における営業取引関係の維持強化のため。③直近３ヶ年における受注工事高の獲得は希薄であるものの、ＲＯＩがＷＡＣＣを超えているため、保有の妥当性がある。④株式数の増加は持株会の加入による取得であり、事業上の同社との関係強化のため継続加入している。","reciprocal":"無","pct_outstanding":0.22713550084705042,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.088966041011175,"pct_of_holder_assets":0.06613756613756613,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":46085000000,"holder_total_assets_yen":61992000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"株式会社ムサシ","holder_name_en":"MUSASHI CO.,LTD.","holder_sec_code":"7521","doc_id":"S100YHDE","period_end":"2026-03-31","holder_table":"reporting","shares":38730,"book_value_yen":33000000,"prior_shares":37479,"prior_book_value_yen":33000000,"purpose_ja":"商品販売及び役務の提供を行っており、円滑な取引関係の維持・強化を図るために保有しております。紙・紙加工品セグメントにおいて保有の合理性を認めます。株式の増加数は、取引先持株会を通じて取得したものであります。(注）１","reciprocal":"無","pct_outstanding":0.1872450128308521,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.08933647364574028,"pct_of_holder_assets":0.06244205188366857,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":36939000000,"holder_total_assets_yen":52849000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"株式会社ＳＣＲＥＥＮホールディングス","holder_name_en":"SCREEN Holdings Co., Ltd.","holder_sec_code":"7735","doc_id":"S100YK9N","period_end":"2026-03-31","holder_table":"reporting","shares":37837,"book_value_yen":33000000,"prior_shares":35880,"prior_book_value_yen":32000000,"purpose_ja":"販売先として事業上の関係を勘案し、同社との良好な関係の維持、強化を図る為、継続して保有しています。当事業年度の増加分につきましては、同社との更なる関係強化の為に取得しています。","reciprocal":"有","pct_outstanding":0.1829276930152582,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0067805804176837535,"pct_of_holder_assets":0.004567973522364383,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":486684000000,"holder_total_assets_yen":722421000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"わかもと製薬株式会社","holder_name_en":"WAKAMOTO PHARMACEUTICAL CO.,LTD.","holder_sec_code":"4512","doc_id":"S100YDBU","period_end":"2026-03-31","holder_table":"reporting","shares":32000,"book_value_yen":27968000,"prior_shares":32000,"prior_book_value_yen":28768000,"purpose_ja":"医薬事業、ヘルスケア事業、グローバル事業における仕入先であり、取引関係の維持・強化のため保有しています。","reciprocal":"有","pct_outstanding":0.15470798891265858,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.23290012366989904,"pct_of_holder_assets":0.16950706765318713,"holder_equity_basis":"parent_only","holder_equity_yen":12008581000,"holder_total_assets_yen":16499607000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"株式会社ＣＣＩグループ","holder_name_en":"CCI Group, Inc.","holder_sec_code":"7381","doc_id":"S100YAOX","period_end":"2026-03-31","holder_table":"largest","shares":30000,"book_value_yen":26000000,"prior_shares":80000,"prior_book_value_yen":71000000,"purpose_ja":"同社との総合的な取引拡大により、地域社会への貢献および企業価値の向上を図るために保有しておりますが、将来的な縮小に向けて対話を進めております。","reciprocal":"無","pct_outstanding":0.14503873960561742,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.010245376773730854,"pct_of_holder_assets":0.0003977489855106164,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":253773000000,"holder_total_assets_yen":6536786000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"トナミホールディングス株式会社","holder_name_en":"Tonami Holdings Co., Ltd.","holder_sec_code":"9070","doc_id":"S100W6N2","period_end":"2025-03-31","holder_table":"reporting","shares":25000,"book_value_yen":22000000,"prior_shares":25000,"prior_book_value_yen":22000000,"purpose_ja":"当社及び連結子会社での営業取引関係の維持・強化のため。","reciprocal":"無","pct_outstanding":0.11762697090459234,"pct_unavailable":null,"pct_basis_period_end":"2025-03-31","pct_share_classes":1,"pct_of_holder_equity":0.023338955899981965,"pct_of_holder_assets":0.012806706056989843,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":94263000000,"holder_total_assets_yen":171785000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"株式会社オリバー","holder_name_en":"OLIVER CORPORATION","holder_sec_code":"7959","doc_id":"S100KNMN","period_end":"2020-10-20","holder_table":"reporting","shares":24000,"book_value_yen":21792000,"prior_shares":24000,"prior_book_value_yen":24024000,"purpose_ja":"営業取引上の関係強化のため","reciprocal":"有","pct_outstanding":0.11032946262334317,"pct_unavailable":null,"pct_basis_period_end":"2022-03-31","pct_share_classes":1,"pct_of_holder_equity":0.06984379437951038,"pct_of_holder_assets":0.055153893713800035,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":31201054000,"holder_total_assets_yen":39511263000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"サカタインクス株式会社","holder_name_en":"SAKATA INX CORPORATION","holder_sec_code":"4633","doc_id":"S100XSP9","period_end":"2025-12-31","holder_table":"reporting","shares":17651,"book_value_yen":15000000,"prior_shares":34082,"prior_book_value_yen":30000000,"purpose_ja":"印刷インキ事業における取引先であり、取引関係の維持、強化を目的として保有しております。定量的な保有効果の記載は困難ですが、保有目的や取引状況、配当収益等により合理性を検証のうえ、保有を継続しております。株式数は、取引先持株会の継続加入にともない増加しております。当事業年度において、保有株式の一部を売却しております。","reciprocal":"無","pct_outstanding":0.08533595975929177,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.01185592677779622,"pct_of_holder_assets":0.006641164594623313,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":126519000000,"holder_total_assets_yen":225864000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"竹田ｉＰホールディングス株式会社","holder_name_en":"TAKEDA iP HOLDINGS CO., LTD．","holder_sec_code":"7875","doc_id":"S100YT5G","period_end":"2026-03-31","holder_table":"largest","shares":16800,"book_value_yen":14000000,"prior_shares":16800,"prior_book_value_yen":15000000,"purpose_ja":"（保有目的）情報コミュニケーションにおける企業間取引の強化及び継続受注の確保を目的として保有しております。（定量的な保有効果）（注）１","reciprocal":"有","pct_outstanding":0.08122169417914576,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.07000700070007,"pct_of_holder_assets":0.04039937669533099,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":19998000000,"holder_total_assets_yen":34654000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"王子ホールディングス株式会社","holder_name_en":"Oji Holdings Corporation","holder_sec_code":"3861","doc_id":"S100YJ8J","period_end":"2026-03-31","holder_table":"reporting","shares":16000,"book_value_yen":13000000,"prior_shares":16000,"prior_book_value_yen":14000000,"purpose_ja":"同上","reciprocal":"無","pct_outstanding":0.07735399445632929,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.0011434783908972083,"pct_of_holder_assets":0.00048382102492645923,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":1136882000000,"holder_total_assets_yen":2686944000000,"implausible":false,"reciprocal_held_both_ways":false},{"holder_name":"ダイト株式会社","holder_name_en":"Daito Pharmaceutical Co.,Ltd.","holder_sec_code":"4577","doc_id":"S100YYNI","period_end":"2026-05-31","holder_table":"reporting","shares":13724,"book_value_yen":11000000,"prior_shares":13724,"prior_book_value_yen":11000000,"purpose_ja":"(保有目的) 当社の包装資材の仕入先であり、医薬品原料・資材の円滑な調達を目的として保有しております。","reciprocal":"有","pct_outstanding":0.06635038874491646,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.020779024519248932,"pct_of_holder_assets":0.015008664092453371,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":52938000000,"holder_total_assets_yen":73291000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"北越コーポレーション株式会社","holder_name_en":"Hokuetsu Corporation","holder_sec_code":"3865","doc_id":"S100YITB","period_end":"2026-03-31","holder_table":"reporting","shares":12474,"book_value_yen":10000000,"prior_shares":12474,"prior_book_value_yen":11000000,"purpose_ja":"主要顧客として良好な取引関係の維持、強化を図るため","reciprocal":"有","pct_outstanding":0.060307107928015725,"pct_unavailable":null,"pct_basis_period_end":"2026-03-31","pct_share_classes":1,"pct_of_holder_equity":0.003956525695656131,"pct_of_holder_assets":0.002377702853718965,"holder_equity_basis":"jgaap_consolidated","holder_equity_yen":252747000000,"holder_total_assets_yen":420574000000,"implausible":false,"reciprocal_held_both_ways":true},{"holder_name":"日医工株式会社","holder_name_en":"Nichi-Iko Pharmaceutical Co., Ltd.","holder_sec_code":"4541","doc_id":"S100OLZH","period_end":"2022-03-31","holder_table":"reporting","shares":8316,"book_value_yen":6000000,"prior_shares":8316,"prior_book_value_yen":7000000,"purpose_ja":"(保有目的)当社の仕入先であり、医薬品原料・資材の円滑な調達を目的として保有しております。","reciprocal":"有","pct_outstanding":0.03822915879898841,"pct_unavailable":null,"pct_basis_period_end":"2022-03-31","pct_share_classes":1,"pct_of_holder_equity":0.04479617739286248,"pct_of_holder_assets":0.002302741413652954,"holder_equity_basis":"ifrs_consolidated_excl_nci","holder_equity_yen":13394000000,"holder_total_assets_yen":260559000000,"implausible":false,"reciprocal_held_both_ways":true}],"reclassified":[],"reclassified_note":"As filed, from the annual report's 保有目的を変更した投資株式 table. direction=to_pure means the filer moved the holding from a policy shareholding to 純投資目的 (pure investment); the shares are not necessarily sold, and the position leaves the named policy table in the year of the change. direction=to_policy is the reverse. fy_of_change_ja is the fiscal year the filer states the change took effect, verbatim — some filers list more than one. A filing repeats these rows for several years after the change, so this is a standing disclosure, not a one-year event.","implausible_note":"A row is flagged implausible when its two filed numbers are mutually impossible — book value ÷ shares of ¥1,000,000 or more, which no listed Japanese share reaches. It is a filer tagging error (a value entered at the wrong scale, or a share count in thousands), not an extraction error: the values match the filing's XBRL exactly. Flagged rows are still returned, exactly as filed, but are excluded from the yen aggregates here and counted in excluded_positions / excluded_yen so the exclusion is visible.","notes":[{"holder_table":"reporting","note_no":"1","text_ja":"（注）保有先企業は当社の株式を保有しておりませんが、同社子会社が当社の株式を保有しております。"}],"notes_note":"The filing's own numbered footnotes to the named policy table, verbatim. The XBRL numbers them (注)1, (注)2 … and gives no link back to a row, so a note is tied to a position only where it names that issuer.","flows":[{"holder_table":"reporting","share_class":"listed","issues_increased":8,"acquisition_cost_yen":23000000,"issues_decreased":6,"sale_proceeds_yen":711000000,"entity_scope":"parent_only","share_scope":"listed"},{"holder_table":"reporting","share_class":"unlisted","issues_increased":1,"acquisition_cost_yen":150000000,"issues_decreased":null,"sale_proceeds_yen":null,"entity_scope":"parent_only","share_scope":"unlisted"}],"flows_note":"The filer's own tally, as filed, of how many issues increased or decreased during the year and the yen involved — acquisition cost for increases, sale proceeds for decreases. Read against the reclassification table this separates what was actually sold from what merely changed category. Counts are as filed and are not corrected for filer tagging errors.","no_reduction_measure":"This product holds sale proceeds (売却価額), as filed, for one fiscal year. It does NOT hold a book-value-reduction measure. The two are different measures and must never be presented as equivalent.","scale":{"policy_total_yen":4533000000,"listed_yen":3864000000,"unlisted_yen":669000000,"listed_issues":38,"unlisted_issues":24,"equity_yen":36735000000,"equity_basis":"jgaap_consolidated","total_assets_yen":69175000000,"assets_basis":"jgaap_consolidated","pct_of_equity":12.339730502245814,"pct_of_assets":6.552945428261655,"equity_basis_label":"Consolidated net assets (Japanese GAAP)","assets_basis_label":"Consolidated net assets (Japanese GAAP)","equity_calc":"total policy shareholdings ÷ shareholders' equity × 100, both as filed in this annual securities report","assets_calc":"total policy shareholdings ÷ total assets × 100, both as filed in this annual securities report"},"scale_entities":[{"holder_table":"reporting","share_class":"listed","book_value_yen":3864000000,"issue_count":38,"holder_table_label":"The filer itself","entity_scope":"parent_only","share_scope":"listed"},{"holder_table":"reporting","share_class":"unlisted","book_value_yen":669000000,"issue_count":24,"holder_table_label":"The filer itself","entity_scope":"parent_only","share_scope":"unlisted"}],"scale_history":[{"year":"2022","period_end":"2022-03-31","policy_total_yen":3902266000,"equity_yen":31649279000,"equity_basis":"jgaap_consolidated","pct_of_equity":12.329715315157733,"pct_of_assets":5.637034426888248},{"year":"2023","period_end":"2023-03-31","policy_total_yen":3882118000,"equity_yen":32828260000,"equity_basis":"jgaap_consolidated","pct_of_equity":11.825536900219506,"pct_of_assets":5.959791573909163},{"year":"2024","period_end":"2024-03-31","policy_total_yen":4488583000,"equity_yen":34171990000,"equity_basis":"jgaap_consolidated","pct_of_equity":13.135269558489277,"pct_of_assets":6.533742842546987},{"year":"2025","period_end":"2025-03-31","policy_total_yen":4197354000,"equity_yen":35572091000,"equity_basis":"jgaap_consolidated","pct_of_equity":11.799570624060307,"pct_of_assets":5.9568256398981525},{"year":"2026","period_end":"2026-03-31","policy_total_yen":4533000000,"equity_yen":36735000000,"equity_basis":"jgaap_consolidated","pct_of_equity":12.339730502245814,"pct_of_assets":6.552945428261655}],"scale_note":"The policy total is Official (as filed) — the filing's own total carrying amount for the whole policy bucket, listed and unlisted, summed across the entities the filing discloses. It is a floor: holdings at group companies the filing does not name are disclosed nowhere and are not included. The percentages are calculated, not filed, and carry their formula. equity_basis names which figure the denominator is, because filers report under Japanese, IFRS or US accounting standards and an adopter of the latter two stops tagging the Japanese consolidated figure — a parent-only denominator is a different measure and is labelled as one, never silently mixed with a group figure. Percentages are null where equity or total assets is missing or not positive; missing is never shown as zero.","scale_reference":"ISS's Japan proxy voting guidelines recommend a vote against the top executive at a company that allocates 20 percent or more of its net assets to cross-shareholdings, a policy effective from February 2022. ISS counts unilateral holdings, not only mutual ones.","ownership_calc":"shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end","ownership_note":"Derived, not filed. The denominator is the issuer's own reported issued shares less treasury shares, from its annual report nearest this holding's fiscal year end on either side — pct_basis_period_end gives that date, and it can fall after the holding's date where that report is the closer one. For a single-class listed stock this equals the stake's share of market capitalisation. It is null where the issuer files no annual report we hold; where the issuer's share count moves by half or more across the window, because a split or issue makes the share base indeterminate; and where the result would exceed 100%, which is a data fault rather than a stake. It is less exact where the issuer has more than one share class (pct_share_classes > 1), because treasury shares are reported across all classes.","holder_share_calc":"this position's book value ÷ the holder's shareholders' equity (or total assets) × 100, both as filed in the holder's own annual securities report","holder_share_note":"The mirror of pct_outstanding. That sizes a stake against the ISSUER — how much of the issuer this holder owns. pct_of_holder_equity and pct_of_holder_assets size the same position against the HOLDER: how much of its own capital is committed to this one name. Calculated, not filed. Null where the holder's filing gives no usable denominator, never zero. holder_equity_basis says which accounting figure the denominator is, and a parent_only basis is not comparable with a consolidated one. A position CAN legitimately exceed 100% of equity — a holder whose book equity is smaller than one long-held stake is a real and commercially interesting case, not an error — so no ceiling is imposed. Extreme values are worth checking against the filing: where the position's own two filed numbers are mutually impossible the row is marked `implausible`, but that test catches only scale errors visible per share, so it does not catch every bad figure. The book value and share count are returned alongside so the reader can check.","action_calc":"keyword match over the filing's own stated purpose and table footnotes: 株式分割、株式併合、株式交換、株式移転、会社分割、合併、持株会社、商号変更、公開買付、上場廃止","ratio_calc":"current shares ÷ prior shares where that ratio is an exact whole number (or its exact reciprocal) — the signature of a split or a consolidation rather than a trade","history":[{"year":"2022","period_end":"2022-03-31","named_holdings":45,"book_value_yen":3415695000},{"year":"2023","period_end":"2023-03-31","named_holdings":43,"book_value_yen":3356603000},{"year":"2024","period_end":"2024-03-31","named_holdings":42,"book_value_yen":3968825000},{"year":"2025","period_end":"2025-03-31","named_holdings":42,"book_value_yen":3677597000},{"year":"2026","period_end":"2026-03-31","named_holdings":41,"book_value_yen":3848000000}],"history_note":"One point per annual report filed. Each year's book value is as filed; book values are fair-valued at period end, so a change reflects both trading and market moves.","provenance":{"trust":"official","note":"Figures exactly as filed in each company's 有価証券報告書 (annual securities report), EDINET. Raw filings archived with SHA-256; doc_id links to the source filing."}}